CH665355A5 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung. Download PDF

Info

Publication number
CH665355A5
CH665355A5 CH3039/85A CH303985A CH665355A5 CH 665355 A5 CH665355 A5 CH 665355A5 CH 3039/85 A CH3039/85 A CH 3039/85A CH 303985 A CH303985 A CH 303985A CH 665355 A5 CH665355 A5 CH 665355A5
Authority
CH
Switzerland
Prior art keywords
warm
purified
blooded animals
mice
endotoxin
Prior art date
Application number
CH3039/85A
Other languages
German (de)
English (en)
Inventor
Edgar Ernst Ribi
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of CH665355A5 publication Critical patent/CH665355A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CH3039/85A 1984-07-12 1985-07-12 Pharmazeutische zusammensetzung. CH665355A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/630,013 US4629722A (en) 1984-07-12 1984-07-12 Method of inhibiting the onset of acute radiation syndrome

Publications (1)

Publication Number Publication Date
CH665355A5 true CH665355A5 (de) 1988-05-13

Family

ID=24525404

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3039/85A CH665355A5 (de) 1984-07-12 1985-07-12 Pharmazeutische zusammensetzung.

Country Status (14)

Country Link
US (1) US4629722A (enExample)
JP (1) JPS6193123A (enExample)
KR (1) KR880000191B1 (enExample)
AU (1) AU556971B2 (enExample)
BE (1) BE902875A (enExample)
CH (1) CH665355A5 (enExample)
DE (2) DE3546592C2 (enExample)
FR (1) FR2567403A1 (enExample)
GB (1) GB2161381B (enExample)
IL (1) IL75789A (enExample)
IT (1) IT1214671B (enExample)
NL (1) NL8501995A (enExample)
NZ (1) NZ212691A (enExample)
ZA (1) ZA855243B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866034A (en) * 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US5354782A (en) * 1991-01-17 1994-10-11 Merrell Dow Pharmaceuticals Inc. Polyamine phenols as radioprotective agents
US5530113A (en) * 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
AU660325B2 (en) * 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
KR101378872B1 (ko) 2006-09-26 2014-04-11 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) 합성 애주번트를 함유하는 백신 조성물
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
SI2437753T1 (sl) 2009-06-05 2016-12-30 Infectious Disease Research Institute Sintetični glukopiranozil-lipidni adjuvansi in cepivni sestavki, ki jih vsebujejo
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
PT2850431T (pt) 2012-05-16 2018-07-23 Immune Design Corp Vacinas para hsv-2
EP3711768A1 (en) 2013-04-18 2020-09-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
IL295025A (en) * 2014-09-16 2022-09-01 Bioincept Llc Preparations and methods for the treatment of acute radiation syndrome
EP3341739A4 (en) 2015-08-28 2019-07-10 BioIncept LLC MUTATED PEPTIDES AND METHOD FOR TREATING SUBJECTS THEREWITH
EP3341006A4 (en) 2015-08-28 2019-03-13 BioIncept LLC COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE
KR101909660B1 (ko) * 2017-07-06 2018-10-18 이보미 안경알 자판기 서비스 제공 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1225592A (en) * 1983-08-26 1987-08-18 Ribi Immunochem Research Inc. Refined detoxified endotoxin

Also Published As

Publication number Publication date
JPS6234733B2 (enExample) 1987-07-28
JPS6193123A (ja) 1986-05-12
IT1214671B (it) 1990-01-18
GB8517545D0 (en) 1985-08-14
KR880000191B1 (ko) 1988-03-12
ZA855243B (en) 1986-02-26
FR2567403A1 (fr) 1986-01-17
BE902875A (fr) 1985-11-04
KR860000867A (ko) 1986-02-20
US4629722A (en) 1986-12-16
GB2161381A (en) 1986-01-15
NL8501995A (nl) 1986-02-03
DE3524992A1 (de) 1986-01-16
AU4475885A (en) 1986-01-16
IL75789A0 (en) 1985-11-29
IT8548347A0 (it) 1985-07-12
DE3546592C2 (enExample) 1988-06-01
DE3524992C2 (enExample) 1988-05-11
NZ212691A (en) 1988-02-12
GB2161381B (en) 1988-01-13
AU556971B2 (en) 1986-11-27
IL75789A (en) 1990-04-29

Similar Documents

Publication Publication Date Title
DE69927125T2 (de) Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels
DE2934069C2 (enExample)
DE69713485T2 (de) Medikamente für die Behandlung oder Vorbeugung von Thrombocytopenie
DE69715862T2 (de) Verwendung eines k-252a derivats zur behandlung von periphärer oder zentraler nervenerkrankungen und übermässiger cytokinbildung
DE3524992C2 (enExample)
EP0759295A1 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
CH654212A5 (de) Zubereitung zur steigerung der therapeutischen wirkung eines antitumormittels und diese zubereitung enthaltende antitumor-zubereitung.
DE3786304T2 (de) Immunostimulierende Arzneimittel.
DE3916417C2 (enExample)
DE2919514C2 (de) 1-(2,3-Di-n-alkoxy-1-propyl)-und 1-(1,3-Di-n-alkoxy-2-propyl)-4-aminomethyl-4-phenyl-piperidine und diese enthaltende Arzneimittel
DE3000139A1 (de) Die verwendung von glyzerinphosphorylderivaten in der therapie der dislipaemie, der hepatitis und vergleichgeeignete pharmazeutische kompositionen
DE2655690A1 (de) Arzneimittelzubereitungen
DE69715895T2 (de) Antimalariamittel mit cis-kondensierten zyklopenteno-1,2,4-trioxanderivate
DE3852717T2 (de) Zusammensetzung für die Prophylaxe von Pneumocystis-carinii-Pneumonie.
DE2445679C3 (de) Stimulierung der Immunität
DE2610426C2 (de) Verwendung eines OEP als Wirkstoff enthaltenden Impfstoffes zur Bekämpfung der durch Pseudomonas aeruginosa hervorgerufenen Pneumonitis der Nerze
DE3141970A1 (de) Arzneimittel zur behandlung der durch den virus der herpes-gruppe erzeugten erkrankungen
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE2161588C3 (de) Mittel zur Behandlung von Hyperlipoproteinämien
DE3643001C2 (enExample)
DE69517672T2 (de) Injizierbare loesung enthaltend benzalkoniumfluorid
WO2001070203A2 (de) Mittel zur behandlung von hepatitis c, enthaltend ukrain
DD232432A5 (de) Verfahren zur herstellung des wirkstoffes eines immunomodulator-medikamentes
DE2110436B2 (de) Verfahren zur Herstellung eines antileukopenischen und antikörperbildenden Thymusextrakts aus Kalbsthymus

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased